My educational qualifications include a Bachelor of Medical and Surgery (MBCHB) and Post Graduate Diploma in Health Economics from the University of Cape Town. I am also completing a B. Com (Economics) degree from the University of South Africa (due to finish at the end of 2019). My clinical experience includes working at two academically astute institutions: Groote Schuur and Red Cross Children’s Hospital in Cape Town. I supplemented this with exposure to rural Medicine in the Eastern Cape at the Nelson Mandela Academic Hospital. In December 2012 I was appointed as a Medical Affairs Manager and Head of Drug Safety at Mylan South Africa. I was the first Medical Doctor to be appointed in Medical Affairs at Mylan South Africa. This was during the launch of the Mylan generic HIV antiretroviral (ARV) franchise and I oversaw the medical training and support of the launch of a sales force team of 15. Mylan was one of three companies which was supplying the first single tablet regimen (TDF/FTC/EFV) ARV tender. I set up systems that have ensured that Mylan South Africa has a robust medical affairs department that provides strategic medical marketing support to the various commercial business units. In my role, I also played an important role in informing strategic portfolio development decisions (particularly within the HIV, Intravenous portfolio, Cardiovascular, Anaphylaxis and CNS arena). My role also included ensuring compliance from a Pharmacovigilance and product safety perspective. Prior to the resignation of our previous managing director and vice president, I was appointed as Head of Business development effective from the 1st of September 2013. This followed from the successful implementation of the medical affairs department at Mylan South Africa. I was therefore tasked with the role of leading the company from a top-level product development perspective and expanding the company’s portfolio through medically informed business development initiatives. This was a great achievement for me as I did not have any prior pharmaceutical experience. Upon the appointment of a new Managing Director in October 2013, I was requested to continue with heading up the medical affairs department. I was rated a 4.5/5 at the end 2013 in my end year performance review. Following the great success I have had in setting up the medical affairs department at Mylan South Africa, I then sought growth opportunities in an originator space at Glaxo Smith Kline. I believed this opportunity would grow my competencies in medical governance and medical marketing within a science-led originator multinational company. In my role as the first Medical Manager for the Southern African Development Community (SADC) region, I provided medical governance and medical support to Commercial (Marketing and Sales) and Regulatory Affairs departments and was responsible for building a network environment for the assigned Consumer Healthcare product portfolio for the GSK Consumer Healthcare Businesses. I supported leading household brands such as Grandpa, Eno, Medlemon, Horlicks, Scotts Emulsion, Aquafresh, Sensodyne and Corsodyl. Subsequent to this role, I joined Gilead Sciences as a Senior Manager in Public Health and Medical Affairs (PHMA) within the Access Operations and Emerging Markets team. Disease area focus includes HIV (treatment and prevention), Viral Hepatitis B and C and Systemic Antifungal treatment. This role partnered with and provided scientific and Health Economic Outcomes Research support to key stakeholders such as Ministries of Health, global funders, NGO’s and key clinician groups in guideline development and healthcare policy formulation to increase access to Gilead’s lifesaving medications in areas of unmet medical need. This role focused on the Sub Sahara region and included being the PHMA lead, reporting into our global structure, in key growth countries like South Africa, Nigeria, Kenya, Tanzania, Ghana, Zambia, Namibia, Botswana and Zimbabwe. I worked with various in-country distribution partners and provided strategic and tactical direction to the various country plans so as to achieve Gilead global objectives in a country specific environment. I had 7 partner contacts reporting into me on matters related to public health and medical affairs. In my last 12 months at Gilead, I had an opportunity to join our commercial team as the lead contact for our regional partners and to formulate marketing and sales strategies to ensure increased utilization of Gilead brands across Sub-Sahara Africa. I was appointed as the PrEP Project Lead for Africa and was responsible for the commercialization of the first oral antiviral agent to prevent HIV. Subsequent to leaving Gilead due to compelling family responsibilities requiring me to be based in South Africa at the time, I had the following locally based roles: • Mylan as Head of Medical Affairs. This was a key role for Mylan as the role supported plans for significant launches in CNS-ADHD, HIV (Self-Testing, PrEP and Treatment-Rilpivirine registration in light of negative Dolutegravir pregnancy safety data), MDR/XDR TB, Oncology (HER-2 Breast Cancer), Anesthetics and Hospital Portfolio and a strong focus on lifestyle diseases including Diabetes. My role was to prepare the scientific landscape for these launches. I also supported the current registered product portfolio. Mylan is currently he fastest growing pharmaceutical company in the private sector in South Africa. • Sanofi Pasteur as Medical Manager (Medical Director Role) reporting into Europe, Middle East and Eurasia. My key focus areas are supporting increased access for vaccinations in People Living with HIV (PLHIV), improving vaccination coverage rates in the pediatric and adolescent populations and working on introducing new vaccination indications such as vaccination in pregnancy and raising awareness for booster vaccines in adolescents and adults. My skills include key stakeholder relationship development and science based medical marketing (strategic positioning of medical products in the market to ensure the health benefits are highlighted to potential clients). I possess strong skills in medical governance and medical affairs including engagement with key external stakeholders such as ministries of health, key opinion leaders and scientific bodies. I also have a strong understanding of the diverse healthcare landscape and regulatory framework within various countries in the Sub Sahara region for various classes of medicinal products (Prescription, Consumer/OTC and Medical Devices). After realizing the discrepancy between HIV and other disease treatment options in first world countries and the South African HIV landscape, I have gone back into clinical practice to address this discrepancy through named patient programs and overall effective chronic disease prevention and management. The delivery model for this innovative delivery of community-based care is a 24 hour point-of-care focused paperless medical system that ensures efficient delivery of healthcare. This is an exciting phase as I thoroughly enjoy individualized patient care. I am currently working as a private general practitioner in the Eastern Cape and am looking to grow my expertise in the medical and surgical space. Prior to leaving the Gauteng space, I was also working with the following organizations: • National Department of Health and am a member of the NDOH Viral Hepatitis Technical Working Group as we gear up to strengthen our national viral hepatitis program. o Part of Hepatitis C directly activng antivirals and Diagnostics Sub-Committee • RxHealth/Umvuzo Consultancy • Trucking Wellness Consultant (National HIV program) • GP HIV consultant to “The Birthing Team” Thank you for taking the time to read this. I would like to express my interest to be part of your organization and hope to hear from you soon. Kind regards, Dr. Malusi Manda Peza C: (***)-***-****